Are Lung Cancers with BRAF Mutations Another Molecularly Defined Subgroup of Patients?
Journal of Clinical Oncology (JCO) Podcast · Journals Online Team
April 11, 20115m 8s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this week's podcast, Dr. Jaine discusses the recent manuscript by Paik and colleagues evaluating BRAF mutations in patients with advanced lung cancer. The potential impact of BRAF mutations and outcomes with current therapies for lung cancer are discussed.